Search

everythinglearnresearchcommunity

for

Search:↓

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Researchers used CRISPR/Cas9 to create a goat with a gene that increased cashmere production by 74.5% without affecting quality.

Overexpressing Tβ4 in goats' hair follicles increases cashmere production and hair follicle growth.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Eating dairy and high glycemic foods may increase the risk of acne.

Kimchi probiotics slightly improved hair density, but more research needed.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.